Cargando…

Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up

Pancreatic neuroendocrine tumors (PNETs) or islet cell tumors are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. Patients with PNET sometimes do not show any symptoms, known as nonfunctioning (NF) sporadic PNET. It is still debatable regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesmana, Cosmas Rinaldi Adithya, Lirendra, Mutiara, Inggriani, Sri, Sudoyo, Aru W., Lesmana, Laurentius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830307/
https://www.ncbi.nlm.nih.gov/pubmed/36636359
http://dx.doi.org/10.1159/000526197
_version_ 1784867642796933120
author Lesmana, Cosmas Rinaldi Adithya
Lirendra, Mutiara
Inggriani, Sri
Sudoyo, Aru W.
Lesmana, Laurentius
author_facet Lesmana, Cosmas Rinaldi Adithya
Lirendra, Mutiara
Inggriani, Sri
Sudoyo, Aru W.
Lesmana, Laurentius
author_sort Lesmana, Cosmas Rinaldi Adithya
collection PubMed
description Pancreatic neuroendocrine tumors (PNETs) or islet cell tumors are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. Patients with PNET sometimes do not show any symptoms, known as nonfunctioning (NF) sporadic PNET. It is still debatable regarding the best approach in the NF for small PNET. Currently, the surgical approach is considered the best; however, it is a highly invasive procedure, and it has a potentially high risk of complications as it requires a skilled and experienced operator. Herewith, we reported a 48-year-old female with incidentaloma of nonfunctioning PNET (NF-PNET) whose tumor has been successfully treated with endoscopic ultrasound guided radiofrequency ablation (EUSRA). There was no adverse event observed during and after the EUS procedure, and even 1 week after the procedure. One year later, abdominal magnetic resonance imaging (MRI) examination was carried out and size of the tumor was significantly getting smaller where it could hardly be seen anymore. After 2 years of follow-up, the latest abdominal MRI study showed no solid part of the tumor could be seen anymore. In conclusion, EUSRA can be an alternative option for incidentaloma of NF-PNET management.
format Online
Article
Text
id pubmed-9830307
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-98303072023-01-11 Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up Lesmana, Cosmas Rinaldi Adithya Lirendra, Mutiara Inggriani, Sri Sudoyo, Aru W. Lesmana, Laurentius Case Rep Gastroenterol Single Case Pancreatic neuroendocrine tumors (PNETs) or islet cell tumors are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. Patients with PNET sometimes do not show any symptoms, known as nonfunctioning (NF) sporadic PNET. It is still debatable regarding the best approach in the NF for small PNET. Currently, the surgical approach is considered the best; however, it is a highly invasive procedure, and it has a potentially high risk of complications as it requires a skilled and experienced operator. Herewith, we reported a 48-year-old female with incidentaloma of nonfunctioning PNET (NF-PNET) whose tumor has been successfully treated with endoscopic ultrasound guided radiofrequency ablation (EUSRA). There was no adverse event observed during and after the EUS procedure, and even 1 week after the procedure. One year later, abdominal magnetic resonance imaging (MRI) examination was carried out and size of the tumor was significantly getting smaller where it could hardly be seen anymore. After 2 years of follow-up, the latest abdominal MRI study showed no solid part of the tumor could be seen anymore. In conclusion, EUSRA can be an alternative option for incidentaloma of NF-PNET management. S. Karger AG 2022-11-07 /pmc/articles/PMC9830307/ /pubmed/36636359 http://dx.doi.org/10.1159/000526197 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Lesmana, Cosmas Rinaldi Adithya
Lirendra, Mutiara
Inggriani, Sri
Sudoyo, Aru W.
Lesmana, Laurentius
Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
title Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
title_full Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
title_fullStr Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
title_full_unstemmed Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
title_short Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
title_sort treatment outcome of endoscopic ultrasound radiofrequency ablation for incidentaloma pancreatic neuroendocrine tumor in young female patient: a 2-year follow-up
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830307/
https://www.ncbi.nlm.nih.gov/pubmed/36636359
http://dx.doi.org/10.1159/000526197
work_keys_str_mv AT lesmanacosmasrinaldiadithya treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup
AT lirendramutiara treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup
AT inggrianisri treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup
AT sudoyoaruw treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup
AT lesmanalaurentius treatmentoutcomeofendoscopicultrasoundradiofrequencyablationforincidentalomapancreaticneuroendocrinetumorinyoungfemalepatienta2yearfollowup